CYP2D6 Antibodies

Santa Cruz Biotechnology provides a broad selection of CYP2D6 monoclonal antibodies for research in pharmacogenomics and drug metabolism. CYP2D6 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP2D6 is a critical enzyme in the cytochrome P450 family, responsible for the metabolism of approximately 25% of all clinically used drugs. Variability in CYP2D6 activity can significantly impact drug efficacy and safety, making it essential for personalized medicine approaches. Understanding the function and regulation of CYP2D6 is vital for optimizing therapeutic strategies and minimizing adverse drug reactions. CYP2D6 monoclonal antibodies enable researchers to explore expression patterns across different tissues and cellular compartments. Investigating CYP2D6 localization and interactions provides crucial information about metabolic pathways and drug processing mechanisms. Research utilizing CYP2D6 monoclonal antibodies helps advance understanding of drug metabolism variations and supports the development of more effective therapeutic approaches. Santa Cruz Biotechnology monoclonal antibodies for CYP2D6 contribute to advancing pharmacogenomic research and improving patient treatment outcomes.